Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues

C Cordon-Cardo, JP O'Brien, J Boccia, D Casals, JR Bertino and MR Melamed

Memorial Sloan-Kettering Cancer Center, New York, New York 10021.

We have characterized the normal human tissue distribution and tumor expression of the human multidrug resistance gene (MDR1) product P- glycoprotein (Pgp) by immunohistochemical staining of frozen tissue sections of human normal and tumor tissues, using three mouse monoclonal antibodies (MAb) which recognize at least two different epitopes of Pgp. Pgp expression on normal human tissues was detected in specialized epithelial cells with secretory/excretory functions, trophoblasts in the placenta, and on endothelial cells of capillary blood vessels at blood-tissue barrier sites. There were significant differences in the staining patterns of these MAb. Mouse MAb HYB-241 and HYB-612 each recognize an extracellular epitope of Pgp, whereas mouse MAb C219 detects a carboxy terminal intracellular epitope and has recently been reported to crossreact with the MDR3 gene product. HYB- 241 and HYB-612 strongly stain endothelial cells and trophoblasts, whereas C219 is weakly positive or unreactive on these cells. Likewise, C219 strongly stains the biliary pole of hepatocytes, skeletal and heart muscle fibers, whereas HYB-241 and HYB-612 are unreactive on these cells. Immunopathological studies were performed on a wide variety of human tumors. Pgp expression on human tumors was most commonly detected in colon. renal, and adrenal carcinomas; rarely in lung and gastric carcinomas and certain germ cell tumors; and was undetectable in breast and endometrial carcinomas tested. Few sarcomas and none of the melanomas, neuroblastomas, gliomas, and pheochromocytomas had detectable Pgp expression. Intensity and pattern of staining varied among different cases of a given tumor type; although homogeneous immunoreactivity was observed, heterogeneity of expression in a single histological section was more common. The finding of Pgp expression in a variety of normal tissues with diverse physiological functions suggests that the role of Pgp may not be limited to excretion of xenobiotics. Pgp expression in capillaries of the brain and testis may explain the failure of drugs such as vincristine and actinomycin-D to penetrate into these tissues, allowing them to remain as pharmacological sanctuaries for malignant cells. Although Pgp expression can now be detected in a variety of human tumors, further studies are needed to establish the possible significance of this finding.

Volume 38, Issue 9, pp. 1277-1287, 09/01/1990
Copyright © 1990 by The Histochemical Society

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				N. Giri, N. Shaik, G. Pan, T. Terasaki, C. Mukai, S. Kitagaki, N. Miyakoshi, and W. F. Elmquist Investigation of the Role of Breast Cancer Resistance Protein (Bcrp/Abcg2) on Pharmacokinetics and Central Nervous System Penetration of Abacavir and Zidovudine in the Mouse Drug Metab. Dispos., August 1, 2008; 36(8): 1476 - 1484. [Abstract] [Full Text] [PDF]

				T. Luckenbach and D. Epel ABCB- and ABCC-type transporters confer multixenobiotic resistance and form an environment-tissue barrier in bivalve gills Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2008; 294(6): R1919 - R1929. [Abstract] [Full Text] [PDF]

				M. Goto, S. Masuda, T. Kiuchi, Y. Ogura, F. Oike, K. Tanaka, S. Uemoto, and K.-i. Inui Relation between mRNA Expression Level of Multidrug Resistance 1/ABCB1 in Blood Cells and Required Level of Tacrolimus in Pediatric Living-Donor Liver Transplantation J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 610 - 616. [Abstract] [Full Text] [PDF]

				S.-Y. Katoh, M. Ueno, and N. Takakura Involvement of MDR1 Function in Proliferation of Tumour Cells J. Biochem., April 1, 2008; 143(4): 517 - 524. [Abstract] [Full Text] [PDF]

				R. Callaghan, E. Crowley, S. Potter, and I. D. Kerr P-glycoprotein: So Many Ways to Turn It On J. Clin. Pharmacol., March 1, 2008; 48(3): 365 - 378. [Abstract] [Full Text] [PDF]

				G. Pan, N. Giri, and W. F. Elmquist Abcg2/Bcrp1 Mediates the Polarized Transport of Antiretroviral Nucleosides Abacavir and Zidovudine Drug Metab. Dispos., July 1, 2007; 35(7): 1165 - 1173. [Abstract] [Full Text] [PDF]

				E. R. Gerstner and R. L. Fine Increased Permeability of the Blood-Brain Barrier to Chemotherapy in Metastatic Brain Tumors: Establishing a Treatment Paradigm J. Clin. Oncol., June 1, 2007; 25(16): 2306 - 2312. [Abstract] [Full Text] [PDF]

				S. Petropoulos, G. M. Kalabis, W. Gibb, and S. G. Matthews Functional Changes of Mouse Placental Multidrug Resistance Phosphoglycoprotein (ABCB1) With Advancing Gestation and Regulation by Progesterone Reproductive Sciences, May 1, 2007; 14(4): 321 - 328. [Abstract] [PDF]

				V. Petrovic, S. Teng, and M. Piquette-Miller REGULATION OF DRUG TRANSPORTERS: DURING INFECTION AND INFLAMMATION Mol. Interv., April 1, 2007; 7(2): 99 - 111. [Abstract] [Full Text] [PDF]

				J. C. Kalvass, E. R. Olson, and G. M. Pollack Pharmacokinetics and Pharmacodynamics of Alfentanil in P-Glycoprotein-Competent and P-Glycoprotein-Deficient Mice: P-Glycoprotein Efflux Alters Alfentanil Brain Disposition and Antinociception Drug Metab. Dispos., March 1, 2007; 35(3): 455 - 459. [Abstract] [Full Text] [PDF]

				C. Kimchi-Sarfaty, J. M. Oh, I.-W. Kim, Z. E. Sauna, A. M. Calcagno, S. V. Ambudkar, and M. M. Gottesman A "Silent" Polymorphism in the MDR1 Gene Changes Substrate Specificity Science, January 26, 2007; 315(5811): 525 - 528. [Abstract] [Full Text] [PDF]

				M. Grube, S. Reuther, H. Meyer zu Schwabedissen, K. Kock, K. Draber, C. A. Ritter, C. Fusch, G. Jedlitschky, and H. K. Kroemer Organic Anion Transporting Polypeptide 2B1 and Breast Cancer Resistance Protein Interact in the Transepithelial Transport of Steroid Sulfates in Human Placenta Drug Metab. Dispos., January 1, 2007; 35(1): 30 - 35. [Abstract] [Full Text] [PDF]

				J. P. Fruehauf, H. Brem, S. Brem, A. Sloan, G. Barger, W. Huang, and R. Parker In vitro Drug Response and Molecular Markers Associated with Drug Resistance in Malignant Gliomas Clin. Cancer Res., August 1, 2006; 12(15): 4523 - 4532. [Abstract] [Full Text] [PDF]

				L. S. Kirschner Emerging Treatment Strategies for Adrenocortical Carcinoma: A New Hope J. Clin. Endocrinol. Metab., January 1, 2006; 91(1): 14 - 21. [Abstract] [Full Text] [PDF]

				N. Nishio, T. Katsura, K. Ashida, M. Okuda, and K.-i. Inui MODULATION OF P-GLYCOPROTEIN EXPRESSION IN HYPERTHYROID RAT TISSUES Drug Metab. Dispos., November 1, 2005; 33(11): 1584 - 1587. [Abstract] [Full Text] [PDF]

				A. A. Mathias, J. Hitti, and J. D. Unadkat P-glycoprotein and breast cancer resistance protein expression in human placentae of various gestational ages Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2005; 289(4): R963 - R969. [Abstract] [Full Text] [PDF]

				G. M. Kalabis, A. Kostaki, M. H. Andrews, S. Petropoulos, W. Gibb, and S. G. Matthews Multidrug Resistance Phosphoglycoprotein (ABCB1) in the Mouse Placenta: Fetal Protection Biol Reprod, October 1, 2005; 73(4): 591 - 597. [Abstract] [Full Text] [PDF]

				D. Kolwankar, D. D. Glover, J. A. Ware, and T. S. Tracy EXPRESSION AND FUNCTION OF ABCB1 AND ABCG2 IN HUMAN PLACENTAL TISSUE Drug Metab. Dispos., April 1, 2005; 33(4): 524 - 529. [Abstract] [Full Text] [PDF]

				W. S. Putnam, J. M. Woo, Y. Huang, and L. Z. Benet Effect of the MDR1 C3435T Variant and P-Glycoprotein Induction on Dicloxacillin Pharmacokinetics J. Clin. Pharmacol., April 1, 2005; 45(4): 411 - 421. [Abstract] [Full Text] [PDF]

				V. Sharma, J. L. Prior, M. G. Belinsky, G. D. Kruh, and D. Piwnica-Worms Characterization of a 67Ga/68Ga Radiopharmaceutical for SPECT and PET of MDR1 P-Glycoprotein Transport Activity In Vivo: Validation in Multidrug-Resistant Tumors and at the Blood-Brain Barrier J. Nucl. Med., February 1, 2005; 46(2): 354 - 364. [Abstract] [Full Text] [PDF]

				B. Bauer, A. M. S. Hartz, G. Fricker, and D. S. Miller Modulation of p-Glycoprotein Transport Function at the Blood-Brain Barrier Experimental Biology and Medicine, February 1, 2005; 230(2): 118 - 127. [Abstract] [Full Text] [PDF]

				K. W. Hardy, J. F. S. Crocker, H. McLellan, K. B. Goralski, K. W. Renton, and P. D. Acott Paradoxical Cyclosporine A Requirements in Pediatric Renal Transplants Receiving High-Dose Steroids J. Clin. Pharmacol., February 1, 2005; 45(2): 161 - 167. [Abstract] [Full Text] [PDF]

				U. Puhlmann, C. Ziemann, G. Ruedell, H. Vorwerk, D. Schaefer, C. Langebrake, P. Schuermann, U. Creutzig, and D. Reinhardt Impact of the Cyclooxygenase System on Doxorubicin-Induced Functional Multidrug Resistance 1 Overexpression and Doxorubicin Sensitivity in Acute Myeloid Leukemic HL-60 Cells J. Pharmacol. Exp. Ther., January 1, 2005; 312(1): 346 - 354. [Abstract] [Full Text] [PDF]

				M. Uhr, C. Namendorf, M. T. Grauer, M. Rosenhagen, and M. Ebinger P-glycoprotein is a factor in the uptake of dextromethorphan, but not of melperone, into the mouse brain: evidence for an overlap in substrate specificity between P-gp and CYP2D6 J Psychopharmacol, December 1, 2004; 18(4): 509 - 515. [Abstract] [PDF]

				T. Mitin, L. L. von Moltke, M. H. Court, and D. J. Greenblatt LEVOTHYROXINE UP-REGULATES P-GLYCOPROTEIN INDEPENDENT OF THE PREGNANE X RECEPTOR Drug Metab. Dispos., August 1, 2004; 32(8): 779 - 782. [Abstract] [Full Text] [PDF]

				D. Geromin, J.-F. Bourge, A. Soulie, R. Pawliuk, C. Fleet, E. Michel, Y. Denizot, C. Berthou, P. Leboulch, F. Sigaux, et al. Glycoprotein 170 Induces Platelet-Activating Factor Receptor Membrane Expression and Confers Tumor Cell Hypersensitivity to NK-Dependent Cell Lysis J. Immunol., March 15, 2004; 172(6): 3604 - 3611. [Abstract] [Full Text] [PDF]

				M. T. Grauer and M. Uhr P-glycoprotein reduces the ability of amitriptyline metabolites to cross the blood brain barrier in mice after a 10-day administration of amitriptyline J Psychopharmacol, March 1, 2004; 18(1): 66 - 74. [Abstract] [PDF]

				V. Castagne, L. Bonhomme-Faivre, S. Urien, M. B. Reguiga, M. Soursac, F. Gimenez, and R. Farinotti EFFECT OF RECOMBINANT INTERLEUKIN-2 PRETREATMENT ON ORAL AND INTRAVENOUS DIGOXIN PHARMACOKINETICS AND P-GLYCOPROTEIN ACTIVITY IN MICE Drug Metab. Dispos., February 1, 2004; 32(2): 168 - 171. [Abstract] [Full Text] [PDF]

				Y.-H. Wang, D. R. Jones, and S. D. Hall PREDICTION OF CYTOCHROME P450 3A INHIBITION BY VERAPAMIL ENANTIOMERS AND THEIR METABOLITES Drug Metab. Dispos., February 1, 2004; 32(2): 259 - 266. [Abstract] [Full Text] [PDF]

				S. Taniguchi, Y. Mochida, T. Uchiumi, T. Tahira, K. Hayashi, K. Takagi, M. Shimada, Y. Maehara, H. Kuwano, S. Kono, et al. Genetic polymorphism at the 5' regulatory region of multidrug resistance 1 (MDR1) and its association with interindividual variation of expression level in the colon Mol. Cancer Ther., December 1, 2003; 2(12): 1351 - 1359. [Abstract] [Full Text] [PDF]

				S. Ledoux, R. Yang, G. Friedlander, and D. Laouari Glucose Depletion Enhances P-Glycoprotein Expression in Hepatoma Cells: Role of Endoplasmic Reticulum Stress Response Cancer Res., November 1, 2003; 63(21): 7284 - 7290. [Abstract] [Full Text] [PDF]

				C. Joukhadar, H. Stass, U. Muller-Zellenberg, E. Lackner, F. Kovar, E. Minar, and M. Muller Penetration of Moxifloxacin into Healthy and Inflamed Subcutaneous Adipose Tissues in Humans Antimicrob. Agents Chemother., October 1, 2003; 47(10): 3099 - 3103. [Abstract] [Full Text] [PDF]

				B. Schroppel and B. Murphy Gene Variants Affecting Bioavailability of Drugs: Towards Individualized Immunosuppressive Therapy? J. Am. Soc. Nephrol., July 1, 2003; 14(7): 1955 - 1957. [Full Text] [PDF]

				E. M. Kemper, A. E. van Zandbergen, C. Cleypool, H. A. Mos, W. Boogerd, J. H. Beijnen, and O. van Tellingen Increased Penetration of Paclitaxel into the Brain by Inhibition of P-Glycoprotein Clin. Cancer Res., July 1, 2003; 9(7): 2849 - 2855. [Abstract] [Full Text] [PDF]

				P. Pavek, F. Staud, Z. Fendrich, H. Sklenarova, A. Libra, M. Novotna, M. Kopecky, M. Nobilis, and V. Semecky Examination of the Functional Activity of P-glycoprotein in the Rat Placental Barrier Using Rhodamine 123 J. Pharmacol. Exp. Ther., June 1, 2003; 305(3): 1239 - 1250. [Abstract] [Full Text] [PDF]

				F. Imbert, M. Jardin, C. Fernandez, J. C. Gantier, F. Dromer, G. Baron, F. Mentre, L. van Beijsterveldt, E. Singlas, and F. Gimenez Effect of Efflux Inhibition on Brain Uptake of Itraconazole in Mice Infected with Cryptococcus neoformans Drug Metab. Dispos., March 1, 2003; 31(3): 319 - 325. [Abstract] [Full Text] [PDF]

				L. Campbell, A.-N. G. Abulrob, L. E. Kandalaft, S. Plummer, A. J. Hollins, A. Gibbs, and M. Gumbleton Constitutive Expression of P-Glycoprotein in Normal Lung Alveolar Epithelium and Functionality in Primary Alveolar Epithelial Cultures J. Pharmacol. Exp. Ther., January 1, 2003; 304(1): 441 - 452. [Abstract] [Full Text] [PDF]

				D. Virgintino, D. Robertson, M. Errede, V. Benagiano, F. Girolamo, E. Maiorano, L. Roncali, and M. Bertossi Expression of P-Glycoprotein in Human Cerebral Cortex Microvessels J. Histochem. Cytochem., December 1, 2002; 50(12): 1671 - 1676. [Abstract] [Full Text] [PDF]

				R. H. Stephens, J. Tanianis-Hughes, N. B. Higgs, M. Humphrey, and G. Warhurst Region-Dependent Modulation of Intestinal Permeability by Drug Efflux Transporters: In Vitro Studies in mdr1a(-/-) Mouse Intestine J. Pharmacol. Exp. Ther., December 1, 2002; 303(3): 1095 - 1101. [Abstract] [Full Text] [PDF]

				N. Melaine, M.-O. Lienard, I. Dorval, C. Le Goascogne, H. Lejeune, and B. Jegou Multidrug Resistance Genes and P-Glycoprotein in the Testis of the Rat, Mouse, Guinea Pig, and Human Biol Reprod, December 1, 2002; 67(6): 1699 - 1707. [Abstract] [Full Text] [PDF]

				W. Pfutzner, A. Terunuma, C. L. Tock, E. K. Snead, T. M. Kolodka, M. M. Gottesman, L. Taichman, and J. C. Vogel Topical colchicine selection of keratinocytes transduced with the multidrug resistance gene (MDR1) can sustain and enhance transgene expression in vivo PNAS, October 1, 2002; 99(20): 13096 - 13101. [Abstract] [Full Text] [PDF]

				M. Siegsmund, U. Brinkmann, E. Schaffeler, G. Weirich, M. Schwab, M. Eichelbaum, P. Fritz, O. Burk, J. Decker, P. Alken, et al. Association of the P-Glycoprotein Transporter MDR1C3435T Polymorphism with the Susceptibility to Renal Epithelial Tumors J. Am. Soc. Nephrol., July 1, 2002; 13(7): 1847 - 1854. [Abstract] [Full Text] [PDF]

				J. R. Murren Modulating Multidrug Resistance: Can We Target this Therapy? Clin. Cancer Res., March 1, 2002; 8(3): 633 - 635. [Full Text] [PDF]

				G. D. Luker, J. L. Dahlheimer, R. E. Ostlund Jr., and D. Piwnica-Worms Decreased hepatic accumulation and enhanced esterification of cholesterol in mice deficient in mdr1a and mdr1b P-glycoproteins J. Lipid Res., September 1, 2001; 42(9): 1389 - 1394. [Abstract] [Full Text] [PDF]

				S. Larriba, L. Bassas, S. Egozcue, J. Gimenez, M. D. Ramos, O. Briceno, X. Estivill, and T. Casals Adenosine Triphosphate-Binding Cassette Superfamily Transporter Gene Expression in Severe Male Infertility Biol Reprod, August 1, 2001; 65(2): 394 - 400. [Abstract] [Full Text] [PDF]

				J. H. Hochman, M. Chiba, M. Yamazaki, C. Tang, and J. H. Lin P-glycoprotein-Mediated Efflux of Indinavir Metabolites in Caco-2 Cells Expressing Cytochrome P450 3A4 J. Pharmacol. Exp. Ther., July 1, 2001; 298(1): 323 - 330. [Abstract] [Full Text]

				K. W. Scotto and R. A. Johnson Transcription of MDR1: A Therapeutic Target Mol. Interv., June 1, 2001; 1(2): 117 - 125. [Abstract] [Full Text] [PDF]

				M. H. Kang, W. D. Figg, Y. Ando, M. V. Blagosklonny, D. Liewehr, T. Fojo, and S. E. Bates The P-Glycoprotein Antagonist PSC 833 Increases the Plasma Concentrations of 6{{alpha}}-Hydroxypaclitaxel, a Major Metabolite of Paclitaxel Clin. Cancer Res., June 1, 2001; 7(6): 1610 - 1617. [Abstract] [Full Text] [PDF]

				Y.-H. Han, D. H. Sweet, D.-N. Hu, and J. B. Pritchard Characterization of a Novel Cationic Drug Transporter in Human Retinal Pigment Epithelial Cells J. Pharmacol. Exp. Ther., April 13, 2001; 296(2): 450 - 457. [Abstract] [Full Text]

				D. Laouari, R. Yang, C. Veau, I. Blanke, and G. Friedlander Two apical multidrug transporters, P-gp and MRP2, are differently altered in chronic renal failure Am J Physiol Renal Physiol, April 1, 2001; 280(4): F636 - F645. [Abstract] [Full Text] [PDF]

				F. Brouillard, D. Tondelier, A. Edelman, and M. Baudouin-Legros Drug Resistance Induced by Ouabain via the Stimulation of MDR1 Gene Expression in Human Carcinomatous Pulmonary Cells Cancer Res., February 1, 2001; 61(4): 1693 - 1698. [Abstract] [Full Text]

				M. V. St-Pierre, M. A. Serrano, R. I. R. Macias, U. Dubs, M. Hoechli, U. Lauper, P. J. Meier, and J. J. G. Marin Expression of members of the multidrug resistance protein family in human term placenta Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2000; 279(4): R1495 - R1503. [Abstract] [Full Text] [PDF]

				M.-A. Wioland, J. Fleury–Feith, P. Corlieu, F. Commo, G. Monceaux, J. Lacau-St-Guily, and J.-F. Bernaudin CFTR, MDR1, and MRP1 Immunolocalization in Normal Human Nasal Respiratory Mucosa J. Histochem. Cytochem., September 1, 2000; 48(9): 1215 - 1222. [Abstract] [Full Text]

				J. H. Hochman, M. Chiba, J. Nishime, M. Yamazaki, and J. H. Lin Influence of P-Glycoprotein on the Transport and Metabolism of Indinavir in Caco-2 Cells Expressing Cytochrome P-450 3A4 J. Pharmacol. Exp. Ther., January 1, 2000; 292(1): 310 - 318. [Abstract] [Full Text]

				S. P. Letrent, G. M. Pollack, K. R. Brouwer, and K. L.R. Brouwer Effects of a Potent and Specific P-Glycoprotein Inhibitor on the Blood-Brain Barrier Distribution and Antinociceptive Effect of Morphine in the Rat Drug Metab. Dispos., July 1, 1999; 27(7): 827 - 834. [Abstract] [Full Text]

				S. Song, H. Suzuki, R. Kawai, and Y. Sugiyama Effect of PSC 833, a P-Glycoprotein Modulator, on the Disposition of Vincristine and Digoxin in Rats Drug Metab. Dispos., June 1, 1999; 27(6): 689 - 694. [Abstract] [Full Text]

				G. D. Luker, K. R. Nilsson, D. F. Covey, and D. Piwnica-Worms Multidrug Resistance (MDR1) P-glycoprotein Enhances Esterification of Plasma Membrane Cholesterol J. Biol. Chem., March 12, 1999; 274(11): 6979 - 6991. [Abstract] [Full Text] [PDF]